Andreas ('Anoop') Bender, PhD

Lecturer at the Unilever Centre for Molecular Science Informatics, part of the Department of Chemistry of the University of Cambridge. Coming to town? Just let me know and we will go for Formal Hall or a good round of punting!

The Bayer Early Excellence in Science Award for 2011 in the Chemistry category will be awarded to me in early 2012 in a ceremony in Cambridge.

The Prize for Innovations in Pharmaceutical and Medicinal Chemistry 2011 from the German Chemical and Pharmaceutical Societies (GDCh and DPhG) has been awarded jointly to me. The prize will be awarded at the Frontiers in Medicinal Chemistry conference in Saarbruecken in March 2011.

We continuously have PhD and postdoc positions in our lab in the Unilever Centre for Molecular Science Informatics available. Please just contact me if you are interested to join in.

The Handbook of Chemoinformatics Algorithms edited by Jean-Loup Faulon and me was published.






My Chromosomes


Next talks:

Symposium on Computational Chemical Biology
Manchester, UK, 13 September 2012

22nd International Symposium on Medicinal Chemistry (EFMC-ISMC 2012)
Berlin, Germany, 2-6 September 2012

RIKEN Chemical Biology Symposium
Wako, Japan, 20-21 October 2011

47th International Conference on Medicinal Chemistry (Plenary Lecture)
Lyon, France, 6-8 July 2011

Frontiers in Medicinal Chemistry 2011
Saarbruecken, Germany, 20-23 March 2011

Global Discovery & Development Innovation Forum 2011
London, U. K., 7-8 March 2011

World Drug Discovery & Development Summit 2010
Copenhagen, Denmark, 26-27 October 2010

XIXth LACDR School on Medicinal Chemistry
Oegstgeest, The Netherlands, 19-22 October 2010

UK QSAR Meeting Fall 2010
Cambridge, UK, 12 October 2010

FIGON Dutch Medicines Days 2010
Lunteren, The Netherlands, 4-6 October 2010

21st International Symposium on Medicinal Chemistry
Brussels, Belgium, 5-9 September 2010

Second Strasbourg Summer School on Chemoinformatics
Obernai, France, 20-24 June 2010

Bio-IT World 2010
Boston/MA, 20-22 April 2010

British Toxicology Society Annual Meeting 2010
Edinburgh, 28-31 March 2010

In silico discovery of molecular probes and drug-like compounds: Success & Challenges
Ile de France, France, 23-25 March 2010

Fragment-Based Lead Design 2009
York/UK, 20-23 September 2009

DrugInfoMeet
Cochin/India, 19-21 August 2009

Bio-IT World Conference & Expo
Boston/USA, 27-29 April 2009

Addis Ababa University
Addis Ababa/Ethiopia, 9 January 2009

MIPTEC '08
Basel/Switzerland, 14-16 October 2008

Virtual Discovery Europe
Amsterdam/The Netherlands, 19-20 June 2008

8th International Conference on Chemical Structures
Noordwijkerhout/The Netherlands, 1-5 June 2008

Bio-IT World Conference & Expo
Boston/USA, 28-30 April 2008

6th Annual Congress: G Protein-Coupled Receptors in Drug Discovery
Berlin/Germany, 10-13 March 2008







Recent publications (More Publications)
84. Understanding and Classifying Metabolite Space and Metabolite-Likeness.
Julio E. Peironcely, Theo Reijmers, Leon Coulier, Andreas Bender and Thomas Hankemeier, PLoS One 2011 e28966.


read article
(online from 14 December 2011)
83. Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development.
Gerard J.P. van Westen, Jörg K. Wegner, Peggy Geluykens, Leen Kwanten, Inge Vereycken, Anik Peeters, Adriaan P. IJzerman, Herman W.T. van Vlijmen and Andreas Bender, PLoS One 2011 e27518.


read article
82. The challenges involved in Modeling Toxicity Data in silico: A Review.
M. Paul Gleeson, Sandeep Modi, Andreas Bender, Richard L. Marchese Robinson, Johannes Kirchmair, Malinee Promkatkaew, Supa Hannongbua and Robert C. Glen, Curr. Pharm. Des. 2011 (in press).


read article
81. Substructure-Based Virtual Screening for Adenosine A2A Receptor Ligands.
Eelke van der Horst, Rianne van der Pijl, Thea Mulder-Krieger, Andreas Bender, and Adriaan P. IJzerman, ChemMedChem 2011 (12) 2302 - 2311.


read article

80. Collaboration-based Function Prediction in Protein-Protein Interaction Networks.
Hossein Rahmahi, Hendrik Blockeel and Andreas Bender, Proc. IDA (Lect. Notes Comput. Sci.) 2011 (7014) 318 - 327.


read article

79. Interaction-Based Feature Selection for Predicting Cancer-Related Proteins in Protein-Protein Interaction Networks.
Hossein Rahmahi, Hendrik Blockeel and Andreas Bender, Proc. 5th Int. Workshop in Machine Learn. Syst. Biol. (MLSB11) 2011.


read article

78. From in silico target prediction to multi-target drug design: Current databases, methods and applications.
Alexios Koutsoukas, Benjamin Simms, Johannes Kirchmair, Peter J. Bond, Alan V. Whitmore, Steven Zimmer, Malcolm P. Young, Jeremy L. Jenkins, Meir Glick, Robert C. Glen and Andreas Bender, J. Proteomics 2011 (74) 2554 - 2574.


read article

77. Online Chemical Modeling Environment (OCHEM): Web Platform for Data Storage, Model Development and Publishing of Chemical Information.
Iurii Sushko et al., J. Comput.-Aided Mol. Des. 2011 (25) 533 - 554.


read article

76. P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Dataset.
Zhi Wang, Yuanying Chen, Hu Liang, Andreas Bender, Robert Glen and Aixia Yan, J. Chem. Inf. Model 2011 (51) 1447 - 1456.


read article

75. Efficient calculation of compound similarity based on maximum common subgraphs and its application to prediction of gene transcript levels.
Rogier J.P. van Berlo, Marco J.L. de Groot, Andreas Bender, Peter J.T. Verheijen, Marcel J.T. Reinders and Dick de Ridder, Int. J. Bioinf. Res. Appl. 2011 (in press)


read article
74. Diversity-oriented synthesis of macrocyclic peptidomimetics.
Albert Isidro-Llobet, Tiffanie Murillo, Paula Bello, Agostino Cilibrizzia, James T. Hodgkinson, Warren R. J. D. Galloway, Andreas Bender, Martin Welch and David R. Spring, Proc. Natl. Acad. Sci. USA 2011 (108) 6793 - 6798.


read article

73. Increased Diversity of Libraries from Libraries: Chemoinformatic Analysis of Bis-Diazacyclic Libraries.
Fabian Lopez-Vallejo, Adel Nefzi, Andreas Bender, John R. Owen, Ian T. Nabney, Richard A. Houghten and Jose L. Medina-Franco, Chem. Biol. Drug Des. 2011 (77) 328 - 342.


read article

72. Chemogenomics Approaches for Receptor Deorphanization and Extensions of the Chemogenomics Concept to Phenotypic Space.
Eelke van der Horst, Julio E. Peironcely, Gerard J. P. van Westen, Olaf O. van den Hoven, Warren R. J. D. Galloway, David R. Spring, Joerg K. Wegner, Herman W. T. van Vlijmen, Ad P. IJzerman, John P. Overington and Andreas Bender, Curr. Top. Med. Chem. 2011 (11) 1964 - 1977.


read article
71. Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets.
Gerard J. P. van Westen, Joerg K. Wegner, Adriaan P. IJzerman, Herman W. T. van Vlijmen and Andreas Bender, MedChemComm 2011 (2) 16 - 30.


read article

70. Bayesian Methods in Virtual Screening and Chemical Biology.
Andreas Bender, In: Bayesian Methods in Virtual Screening and Chemical Biology, Jurgen Bajorath (Ed.), Meth. Mol. Biol. 2011 (672) 175 - 196.


read article

More Publications

What's up in Bangalore?

According to Maldacena, our universe may be a three-dimensional membrane living in a four-dimensional anti de Sitter space. 'This picture is looking increasingly plausible' says Prof Duff. - The Daily Telegraph, 7 August 2002
I actually like theoretical physicists, but they tend to oversimplify things.

Although antigen expressed in potato for use in humans was effective in animals, the cooking required for human consumption of the vegetable destroyed the immunogenocity of the antigen. - Drug Discovery and Development, H P Rang (ed.), 1st edition, p. 190.
Yep folks, that's science.

Too much information is no information. - unknown

Wer Sicherheit der Freiheit vorzieht ist zu Recht ein Sklave. - Aristoteles
(Those who prefer safety to freedom are slaves, and rightly so.)

Nichts ist einfach wenn man's doppelt nimmt. - My Grandmother
(Nothing to add here).

Wenn ich Du waere, waere ich lieber ich. - Unknown
(If I were you I'd rather be me.)

Der Unterschied zwischen Theorie und Praxis ist in der Theorie groesser als in der Praxis. - Unknown
(The difference between theory and practice is bigger in theory than in practice.)